Actavis Pays $118M To Settle Drug Pricing Claims
Affiliates of generics maker Actavis Group agreed last week to pay $118.6 million to settle claims from the federal government and four states including Iowa and South Carolina in multidistrict litigation...To view the full article, register now.
Already a subscriber? Click here to view full article